JAK inhibitors for the treatment of adult dermatomyositis: A pilot study

J Am Acad Dermatol. 2023 Apr;88(4):924-926. doi: 10.1016/j.jaad.2022.10.055. Epub 2022 Nov 8.
No abstract available

Keywords: JAK inhibitor; autoimmune myopathy; baricitinib; dermatomyositis; interferon; myositis; refractory; ruxolitinib.

MeSH terms

  • Adult
  • Dermatomyositis* / drug therapy
  • Humans
  • Janus Kinase Inhibitors* / therapeutic use
  • Pilot Projects

Substances

  • Janus Kinase Inhibitors